PCG
CHRS icon

Private Capital Group’s Coherus Oncology CHRS Stock Holding History

Private Capital Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,382
Closed -$39K – 2018
2020
Q1 		$39K Buy
2,382
+1,691
+245% +$31.2K 0.01% 747
2019
Q4 		$12K Sell
691
-1,273
-65% -$23.5K ﹤0.01% 1264
2019
Q3 		$40K Buy
+1,964
New +$39.2K 0.01% 867

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Private Capital Group's CHRS Position: Q2 2020 in Review

Private Capital Group sold out of Coherus Oncology (CHRS) in Q2 2020, closing a stake of 2,382 shares — an estimated $39K sold.

Private Capital Group first reported a position in CHRS in Q3 2019 and held it in 3 quarters. The position peaked at $40K in Q3 2019. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2020.

  • Private Capital Group reported no remaining Coherus Oncology position as of Q2 2020 after selling out during the quarter.
  • Private Capital Group sold 2,382 Coherus Oncology shares in Q2 2020, an estimated $39K.
  • Private Capital Group first reported a position in Coherus Oncology in Q3 2019 and held it in 3 quarters.
  • Private Capital Group's Coherus Oncology position peaked at $40K in Q3 2019.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2020.

Based on Private Capital Group's 13F filing for Q2 2020, filed 13 Aug 2020.